Having trouble accessing articles? Reset your cache.

Thiarabine T-araC: Phase I/II started

Access Pharmaceuticals began an open-label, dose-escalation, U.S.

Read the full 78 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE